Nettoinventarwert (NAV)
| 3.96 USD | 0.05 USD | 1.16 % |
|---|
| Vortag | 3.92 USD | Datum | 26.10.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 187.96% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 155.99% | |
| 21shares Ethena ETP | CH1506167035 | 133.37% | |
| 21Shares Stacks ETP | CH1258969042 | 117.24% | |
| 21Shares Arbitrum ETP | CH1304867463 | 108.68% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 232.76% | |
| 21Shares Raydium ETP | CH1480821391 | 140.90% | |
| 21Shares Injective Staking ETP | CH1360612134 | 124.79% | |
| 21Shares Uniswap ETP | CH1135202096 | 116.32% | |
| 21shares Ethena ETP | CH1506167035 | 94.33% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 90.46% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 67.24% | |
| 21Shares Uniswap ETP | CH1135202096 | 5.99% | |
| 21Shares Raydium ETP | CH1480821391 | -6.12% | |
| 21Shares Injective Staking ETP | CH1360612134 | -7.38% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 1’214’661.71 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 28.10.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.